VeriSign Other Non-Current Liabilities decreased by 9.6% to $8.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 15.8%, from $10.10M to $8.50M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -37.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $86.30M | $84.87M | $78.60M | $79.30M | $64.80M | $64.90M | $62.10M | $62.20M | $43.30M | $45.40M | $36.30M | $38.10M | $17.30M | $16.20M | $10.10M | $10.10M | $9.70M | $11.30M | $9.40M | $8.50M |
| QoQ Change | — | -1.7% | -7.4% | +0.9% | -18.3% | +0.2% | -4.3% | +0.2% | -30.4% | +4.8% | -20.0% | +5.0% | -54.6% | -6.4% | -37.7% | +0.0% | -4.0% | +16.5% | -16.8% | -9.6% |
| YoY Change | — | — | — | — | -24.9% | -23.5% | -21.0% | -21.6% | -33.2% | -30.0% | -41.5% | -38.7% | -60.0% | -64.3% | -72.2% | -73.5% | -43.9% | -30.2% | -6.9% | -15.8% |